NovaBay Pharmaceuticals, Inc. (AMEX:NBY) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
NovaBay Pharmaceuticals, Inc.'s stock currently trades at $1.86 with a market capitalization of $17.2M. The Healthcare company's stock moved following the disclosure.